Commentary: Optimizing infliximab therapy for inflammatory bowel disease - The tools are getting sharper

Research output: Contribution to journalComment/Debate

Original languageEnglish
Pages (from-to)134-136
Number of pages3
JournalGastroenterology and Hepatology
Volume8
Issue number2
Publication statusPublished - Feb 2012
Externally publishedYes

Cite this